Advances in Chronic Kidney Disease
Volume 13, Issue 4 , Pages 394-402 , October 2006

Dietary Recommendations for Obese Patients with Chronic Kidney Disease

  • Cheryl A.M. Anderson

      Affiliations

    • Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD
    • Corresponding Author InformationAddress correspondence to Cheryl A. M. Anderson, PhD, MPH, Johns Hopkins University Bloomberg School of Public Health, Department of Epidemiology and the Welch Center for Prevention, Epidemiology, and Clinical Research, 2024 E. Monument Street Baltimore, MD 21205-2223.
    • ,
  • Edgar R. Miller III

      Affiliations

    • National Institute on Aging and Johns Hopkins University School of Medicine, Baltimore, MD.

References 

  1. National Kidney Foundation. KDOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–S266
  2. National Kidney Foundation. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(suppl):1–290
  3. Nelson EE, Hong CD, Pesce AL, et al. Anthropometric norms for the dialysis population. Am J Kidney Dis. 1990;16:32–37
  4. Miller ER, Erlinger TP, Young DR, et al. Results from the Diet Exercise and Weight-Loss Intervention Trial (DEW-IT). Hypertension. 2002;40:612–618
  5. Reddy ST, Wang CY, Sakhaee K, et al. Effect of low-carbohydrate high protein diets on acid base balance, stone forming propensity and calcium metabolism. Am J Kidney Dis. 2002;40:265–274
  6. Johansen KL, Kutner NG, Young B, et al. Association of body size with health status in patients beginning dialysis. Am J Clin Nutr. 2006;83:543–549
  7. Port F, Ashby V, Dhingra R, et al. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol. 2002;13:1061–1066
  8. Kalantar-Zadeh K, Block G, Humphreys MH, et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63:793–808
  9. Saladhudeen AK. Obesity and survival on dialysis. Am J Kidney Dis. 2003;41:925–932
  10. Byers T. Body weight and mortality. N Engl J Med. 1995;333:723–724
  11. Kalantar-Zadeh K, Abbot K, Salahudeen A, et al. Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005;81:543–545
  12. Johansen KL, Kutner NG, Young B, et al. Association of body size with health status in patients beginning dialysis. Am J Clin Nutr. 2006;83:543–549
  13. Klahr S, Levey AS, Beck GH, et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med. 1994;330:877–884
  14. Levey AS, Adler S, Caggiula AW, et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. Am J Kidney Dis. 1996;27:652–663
  15. Levey AS, Greene T, Sarnak MJ, et al. The Effect of Very Low Protein Diet on Progression of Kidney Disease and Mortality in Modification of Diet in Renal Disease Study B. Abstract PO246. American Society of Nephrology; 2004;
  16. National Institute of Diabetes and Digestive and Kidney Diseases. US Renal Data System: USRDS 2004 Annual Data Report. Bethesda, MD: National Institutes of Health; 2004;
  17. Expert Panel on Detection, Evaluation, and Treatment of High Blood Pressure in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497
  18. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: A meta-analysis. Kidney Int. 2001;59:260–269
  19. Tonelli M, Moye L, Sacks FM, et al. Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. J Am Soc Nephrol. 2003;14:1605–1613
  20. Appel LJ, Sacks FM, Carey VJ, et al. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: Results of the OmniHeart randomized trial. JAMA. 2005;294:2455–2464
  21. Grundy SM, Bilheimer D, Blackburn H. Rationale of the diet-heart statement of the American Heart Association. Circulation. 1982;65:839A–854A
  22. Appel LJ, Moore TJ, Obarzanek E, et al. DASH Collaborative Research Group A clinical trial of the effects of dietary patterns on blood pressure. 1997;336:1117–1124
  23. Cowley AW. Genetic and nongenetic determinants of salt sensitivity and blood pressure. Am J Clin Nutr. 1997;65(suppl):587S–593S
  24. Sacks FM, Svetkey LP, Vollmer WM, et al. DASH-Sodium Collaborative Research Group Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med. 2001;344:3–10
  25. Hebert LA, Greene T, Levey A, et al. High urine volume and low urine osmolality are risk factors for faster progression of renal disease. Am J Kidney Dis. 2003;41:962–971

PII: S1548-5595(06)00105-4

doi: 10.1053/j.ackd.2006.07.001

Advances in Chronic Kidney Disease
Volume 13, Issue 4 , Pages 394-402 , October 2006

Article Tools

* Image Usage & Resolution